Latest Clinical research Stories
CLEVELAND, May 12, 2015 /PRNewswire/ -- Driven by the growing demand for drugs of abuse testing solutions in Australasia, two world leading drug testing agencies have joined forces to open
Combined Company to Better Meet the Growing Need for Innovative Patient Data Collection Solutions PHILADELPHIA, PA (PRWEB) May 11, 2015 ERT, a leading
Andrea Valente Brings Broad Industry Experience to Role of Chief Development Officer PHILADELPHIA, PA (PRWEB) May 11, 2015 ERT, a leading global solution
FDAnews has partnered with David Smith of Pepper Hamilton for an analysis of the FDA’s current inspection and enforcement actions regarding 21 CFR part 1271, subpart C which requires human cells,
HAYWARD, Calif., May 11, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S.
-- Initiated Phase 2 for Prevention of C.
FALLS CHURCH, Va., May 11, 2015 /PRNewswire-iReach/ -- If an FDA inspector came to a facility today, would the design control system pass with flying colors? Photo -
RYE, N.Y., May 11, 2015 /PRNewswire/ -- Curemark LLC, a privately held drug research and development company, announced the start of a new Phase III double blind, randomized, placebo-controlled
Reaccreditation underscores WIRB-Copernicus Group's commitment to conducting high-quality clinical research reviews PRINCETON, N.J., May 11, 2015 /PRNewswire/ -- WIRB-Copernicus Group
-Focused on nonprofit organizations that are committed to serving the rare disease community- SOUTH PLAINFIELD, N.J., May 11, 2015 /PRNewswire/ -- PTC Therapeutics, Inc.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.